Welcome to the 5th Annual In-House Impact: Life Sciences Summit 2024

Empowering In-House Teams to Transition from Risk Minimizers to Business-Critical Commercial Partners, Enhancing Strategic Value & Fostering Organizational Growth

Welcome to the In-House Impact: Life Sciences Summit 2024, the premier event tailored exclusively for life sciences General Counsel and Chief Legal Officers to address industry-specific legal challenges. From strategizing for successful IPOs to fostering cross-functional collaboration, cultivating leadership accountability within teams, and championing DE&I amidst funding constraints, this summit offers a unique platform for legal teams to exchange best practices and drive commercial influence within life sciences companies.

This summit is the only event dedicated to uniting in-house members to share exclusive insights and take part in imperative discussions on how legal teams can enact direct commercial influence in Life Sciences Companies. Join 60+ of your fellow GC’s, Chief Legal Officers, Risk Management, and Compliance experts from across leading pharma, biotech, medical device, and pharmaceutical services to successfully navigate developing compliance regulations, exchange strategies in task prioritization, and secure a seat at the table as a commercial leader.

Meet Your Expert Speaker Faculty:

Hear from Our Past Participants:

“Learning from other in-house counsel is so valuable, as we all deal with clients and outside counsel in a specific way. Meeting new people and building my network locally and beyond is priceless”

Takeda Pharmaceuticals

“In-House Impact looks set to occupy a truly unique and invaluable space in the industry, geared specifically towards General Counsels and their in-house teams within Life Sciences, furthering Legal’s role as a critical business growth enabler”

Roche Diagnostics

“This is one of the best conferences I have been to that focused on how to be a better business partner and thereby how to bring real value to our organization. And that is very valuable”

Anavir Pharmaceuticals

“This is my favorite conference annually. The focus on attorneys as business partners and hearing individual and collective experiences of business-focused, revenue-driving attorneys is invaluable”

J. Knipper & Company